Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB26FDV28
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,027
Award facts
- Contract value 100% obligated
- $64,026.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on October 30, 2025, awards AmerisourceBergen Drug Corp $64,026.84 for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. The contract is funded by the Defense Logistics Agency (DLA), a Department of Defense entity responsible for supply chain management across military and federal healthcare systems. The award utilizes firm fixed-price pricing and is structured as a child delivery order under a larger contract vehicle, specifically the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. No small business set-aside was applied to this award, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical supply procurement for military and veteran healthcare systems. As the incumbent prime vendor under the DLA Troop Support Medical contract, the company demonstrates extensive capability in delivering a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. SKYRIZI, a biologic medication used in dermatology, represents one of many specialty pharmaceutical products the company supplies through this strategic federal contract vehicle to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Quick answers
Who was awarded contract SPE2DB26FDV28?
SPE2DB26FDV28 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDV28 worth?
The government has obligated $64,027 on SPE2DB26FDV28.
Is contract SPE2DB26FDV28 an order under another contract?
Yes. SPE2DB26FDV28 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDV28 competed?
The extent of competition for SPE2DB26FDV28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award